Variant report

Variant	nsv830464
Chromosome Location	chr5:119950090-120106717
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1028)
CpG islands
(count:610)
Chromatin interactive
region (count:23)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1028 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr5:120042500-120043085	H1-hESC	embryonic stem cell:	n/a	n/a
2	ATF2	chr5:120031373-120031760	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr5:120030827-120031258	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF2	chr5:120033417-120033942	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr5:120032153-120033315	H1-hESC	embryonic stem cell:	n/a	n/a
6	ATF2	chr5:120042574-120042977	H1-hESC	embryonic stem cell:	n/a	n/a
7	BACH1	chr5:120026709-120027291	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr5:120023318-120023332	K562	blood:	n/a	n/a
9	BACH1	chr5:119959300-119959328	H1-hESC	embryonic stem cell:	n/a	n/a
10	BHLHE40	chr5:119991637-119991644	K562	blood:	n/a	n/a
11	BRCA1	chr5:119974391-119974481	GM12878	blood:	n/a	n/a
12	BRCA1	chr5:120039223-120039493	H1-hESC	embryonic stem cell:	n/a	n/a
13	CCNT2	chr5:120010812-120011012	K562	blood:	n/a	n/a
14	CEBPB	chr5:120102910-120103783	IMR90	lung:	n/a	chr5:120103332-120103343 chr5:120103309-120103322
15	CEBPB	chr5:120103071-120103392	K562	blood:	n/a	chr5:120103332-120103343 chr5:120103309-120103322
16	CEBPB	chr5:120066038-120066233	H1-hESC	embryonic stem cell:	n/a	chr5:120066061-120066072
17	CEBPB	chr5:119977079-119977372	H1-hESC	embryonic stem cell:	n/a	chr5:119977215-119977226
18	CEBPB	chr5:119950210-119950705	IMR90	lung:	n/a	n/a
19	CEBPB	chr5:119951673-119952096	IMR90	lung:	n/a	chr5:119951865-119951878
20	CEBPB	chr5:120065886-120066248	HepG2	liver:	n/a	chr5:120066061-120066072
21	CEBPB	chr5:119993776-119994043	HepG2	liver:	n/a	chr5:119993879-119993890
22	CEBPB	chr5:120054932-120055285	IMR90	lung:	n/a	chr5:120055099-120055108 chr5:120055097-120055108 chr5:120055099-120055110
23	CEBPB	chr5:119984458-119984709	IMR90	lung:	n/a	n/a
24	CEBPB	chr5:119955880-119956197	K562	blood:	n/a	chr5:119956004-119956015
25	CEBPB	chr5:120100946-120101290	IMR90	lung:	n/a	chr5:120101121-120101134
26	CEBPB	chr5:120032291-120032614	IMR90	lung:	n/a	chr5:120032468-120032481
27	CEBPB	chr5:119951672-119952058	Hela-S3	cervix:	n/a	chr5:119951865-119951878
28	CEBPB	chr5:120103253-120103501	H1-hESC	embryonic stem cell:	n/a	chr5:120103332-120103343 chr5:120103309-120103322
29	CEBPB	chr5:120102971-120103502	A549	lung:	n/a	chr5:120103332-120103343 chr5:120103309-120103322
30	CEBPB	chr5:119977078-119977396	HepG2	liver:	n/a	chr5:119977215-119977226
31	CEBPB	chr5:119977083-119977287	K562	blood:	n/a	chr5:119977215-119977226
32	CEBPB	chr5:120042643-120042971	H1-hESC	embryonic stem cell:	n/a	n/a
33	CEBPB	chr5:120065904-120066245	IMR90	lung:	n/a	chr5:120066061-120066072
34	CEBPB	chr5:119981493-119981734	HepG2	liver:	n/a	chr5:119981633-119981644
35	CEBPB	chr5:119984469-119984716	HepG2	liver:	n/a	n/a
36	CEBPB	chr5:120065902-120066254	K562	blood:	n/a	chr5:120066061-120066072
37	CEBPB	chr5:120052476-120052658	A549	lung:	n/a	n/a
38	CEBPB	chr5:120038927-120039237	H1-hESC	embryonic stem cell:	n/a	n/a
39	CEBPB	chr5:120054977-120055190	A549	lung:	n/a	chr5:120055099-120055108 chr5:120055097-120055108 chr5:120055099-120055110
40	CEBPB	chr5:119977083-119977356	IMR90	lung:	n/a	chr5:119977215-119977226
41	CEBPB	chr5:120039460-120039708	H1-hESC	embryonic stem cell:	n/a	chr5:120039507-120039520
42	CEBPB	chr5:120103021-120103545	Hela-S3	cervix:	n/a	chr5:120103332-120103343 chr5:120103309-120103322
43	CEBPB	chr5:120102949-120103507	HepG2	liver:	n/a	chr5:120103332-120103343 chr5:120103309-120103322
44	CEBPB	chr5:120045408-120045601	A549	lung:	n/a	n/a
45	CEBPB	chr5:119959582-119960151	IMR90	lung:	n/a	chr5:119959754-119959765 chr5:119959754-119959767 chr5:119959754-119959767
46	CEBPB	chr5:120030269-120030469	H1-hESC	embryonic stem cell:	n/a	n/a
47	CEBPB	chr5:120065915-120066207	A549	lung:	n/a	chr5:120066061-120066072
48	CEBPB	chr5:120054965-120055296	HepG2	liver:	n/a	chr5:120055099-120055108 chr5:120055097-120055108 chr5:120055099-120055110
49	CEBPB	chr5:119977038-119977401	Hela-S3	cervix:	n/a	chr5:119977215-119977226
50	CEBPB	chr5:119977093-119977344	A549	lung:	n/a	chr5:119977215-119977226

(count:610 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:119952679-119952729	SK-N-SH_RA	brain:	n/a
2	chr5:120040283-120040333	H1-hESC	embryonic stem cell:	embryo
3	chr5:120038342-120038392	GM19239	blood:	n/a
4	chr5:119952679-119952729	NB4	blood:	n/a
5	chr5:120038247-120038297	NT2-D1	testis:	n/a
6	chr5:120018164-120018214	GM19239	blood:	n/a
7	chr5:120097654-120097704	Hepatocyte	liver:	n/a
8	chr5:120026632-120026682	A549	lung:	n/a
9	chr5:120040283-120040333	NT2-D1	testis:	n/a
10	chr5:119951527-119951577	GM12892	blood:	n/a
11	chr5:120040283-120040333	T-47D	breast:	n/a
12	chr5:120069936-120069986	T-47D	breast:	n/a
13	chr5:120018164-120018214	HCM	heart:	n/a
14	chr5:120097654-120097704	AG04449	skin:	fetal
15	chr5:120069936-120069986	PrEC	prostate:	n/a
16	chr5:120069936-120069986	HRPEpiC	eye:	n/a
17	chr5:120040283-120040333	HUVEC	blood vessel:	n/a
18	chr5:120026632-120026682	HNPCEpiC	eye:	n/a
19	chr5:119951527-119951577	SK-N-SH_RA	brain:	n/a
20	chr5:120018164-120018214	AG04450	lung:	fetal
21	chr5:120026632-120026682	U87	brain:	n/a
22	chr5:120038247-120038297	AG09319	gingival:	n/a
23	chr5:120097654-120097704	GM19239	blood:	n/a
24	chr5:120038342-120038392	IMR90	lung:	fetal
25	chr5:120038342-120038392	AoSMC	blood vessel:	n/a
26	chr5:120097654-120097704	Jurkat	blood:	n/a
27	chr5:120069936-120069986	A549	lung:	n/a
28	chr5:120040283-120040333	BE2_C	brain:	n/a
29	chr5:120069936-120069986	HAEpiC	amniotic membrane:	n/a
30	chr5:120038342-120038392	GM06990	blood:	n/a
31	chr5:119952679-119952729	Caco-2	colon:	n/a
32	chr5:120038342-120038392	GM12892	blood:	n/a
33	chr5:120038342-120038392	NH-A	brain:	n/a
34	chr5:120026632-120026682	PANC-1	pancreas:	n/a
35	chr5:120038247-120038297	HUVEC	blood vessel:	n/a
36	chr5:120038342-120038392	SKMC	muscle:	n/a
37	chr5:120040283-120040333	GM06990	blood:	n/a
38	chr5:120040283-120040333	ECC-1	luminal epithelium:	n/a
39	chr5:120018164-120018214	AG09309	skin:	n/a
40	chr5:120026632-120026682	BE2_C	brain:	n/a
41	chr5:120081741-120081791	GM19239	blood:	n/a
42	chr5:119951527-119951577	HCPEpiC	choroid plexus:	n/a
43	chr5:120081741-120081791	HRCEpiC	kidney:	n/a
44	chr5:120038247-120038297	GM19239	blood:	n/a
45	chr5:120097654-120097704	U87	brain:	n/a
46	chr5:120018164-120018214	GM06990	blood:	n/a
47	chr5:119952679-119952729	AG10803	skin:	n/a
48	chr5:119951527-119951577	NHDF-neo	bronchial:	n/a
49	chr5:120038342-120038392	HPAEpiC	pulmonary alveolar:	n/a
50	chr5:120081741-120081791	HRE	kidney:	n/a

(count:23 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:120040953..120043952-chr5:120045648..120047608,2	K562	blood:
2	chr5:119852123..119854010-chr5:120038446..120041236,2	K562	blood:
3	chr5:120072445..120075135-chr5:120093078..120094683,2	K562	blood:
4	chr5:120020785..120023634-chr5:120024255..120028253,3	K562	blood:
5	chr5:119991420..119991957-chr5:121285300..121286207,2	MCF-7	breast:
6	chr5:119980670..119983266-chr5:119989740..119991907,2	K562	blood:
7	chr5:120082635..120085459-chr5:120095219..120098019,2	K562	blood:
8	chr5:120023459..120026241-chr5:120030447..120032911,2	K562	blood:
9	chr5:120076937..120079853-chr5:120080038..120082536,3	K562	blood:
10	chr5:120072445..120075135-chr5:120093078..120094683,2	K562	blood:
11	chr5:120020785..120023634-chr5:120024255..120028253,3	K562	blood:
12	chr5:120082635..120085459-chr5:120095219..120098019,2	K562	blood:
13	chr5:119990484..119993004-chr5:119995293..119997349,2	K562	blood:
14	chr5:119990484..119993004-chr5:119995293..119997349,2	K562	blood:
15	chr5:119991257..119992549-chr5:121285272..121286241,6	MCF-7	breast:
16	chr5:119991277..119991777-chr5:120137719..120138239,2	MCF-7	breast:
17	chr5:119991478..119992421-chr5:120138412..120139232,3	MCF-7	breast:
18	chr5:119980670..119983266-chr5:119989740..119991907,2	K562	blood:
19	chr5:119933357..119934903-chr5:119957823..119959697,2	K562	blood:
20	chr5:120009986..120011754-chr5:120014103..120015876,2	K562	blood:
21	chr5:120076937..120079853-chr5:120080038..120082536,3	K562	blood:
22	chr5:120023459..120026241-chr5:120030447..120032911,2	K562	blood:
23	chr5:120009986..120011754-chr5:120014103..120015876,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LOX-9	chr5:119993772-119994066	NONHSAT103445

No data

Variant related genes	Relation type
ENSG00000270741	TF binding region
RNU4-69P	TF binding region
PRR16	TF binding region
ENSG00000270741	CpG island
RNU4-69P	CpG island
PRR16	CpG island
ENSG00000222609	chromatin interactions

Extended variants
information (count: 5875 )
Associated
traits (count: 74 )

Variant overlapped rSNPs/rCNVs (count:5875 , 50 per page) page: 1 2 3 4 5 6 7 ... 118

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs374384863	chr5:119950102-119950103	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs148967034	chr5:119950118-119950119	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs17428430	chr5:119950138-119950139	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs143711172	chr5:119950144-119950145	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs74535708	chr5:119950180-119950181	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs555310432	chr5:119950226-119950227	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs188915996	chr5:119950230-119950231	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs537670128	chr5:119950237-119950238	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs557515860	chr5:119950300-119950301	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs74401315	chr5:119950307-119950308	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs546277287	chr5:119950309-119950310	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs559544231	chr5:119950317-119950318	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs202023050	chr5:119950396-119950397	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs72792297	chr5:119950405-119950406	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs78530514	chr5:119950427-119950428	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs181292110	chr5:119950505-119950506	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs185687421	chr5:119950607-119950608	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs190004575	chr5:119950608-119950609	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs564295472	chr5:119950635-119950636	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs532928732	chr5:119950652-119950653	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs72792298	chr5:119950659-119950660	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs566532121	chr5:119950664-119950665	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs182770387	chr5:119950700-119950701	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs187320735	chr5:119950734-119950735	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs202176425	chr5:119950747-119950748	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs397769912	chr5:119950756-119950757	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs192374860	chr5:119950764-119950765	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs568805222	chr5:119950794-119950795	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs2405957	chr5:119950805-119950806	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs557319548	chr5:119950841-119950842	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs377363305	chr5:119950927-119950928	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs567882764	chr5:119950959-119950960	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs183691506	chr5:119951044-119951045	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs369482963	chr5:119951070-119951071	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs79021493	chr5:119951072-119951073	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs372839178	chr5:119951074-119951075	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs377168506	chr5:119951079-119951080	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs10717083	chr5:119951080-119951081	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs376780202	chr5:119951115-119951116	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs73254075	chr5:119951136-119951137	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs114622515	chr5:119951157-119951158	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs541852914	chr5:119951169-119951170	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs561728880	chr5:119951199-119951200	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs575190568	chr5:119951210-119951211	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs544490760	chr5:119951290-119951291	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs2124166	chr5:119951294-119951295	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs146474145	chr5:119951310-119951311	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs546442539	chr5:119951315-119951316	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs559803107	chr5:119951332-119951333	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs560310980	chr5:119951372-119951373	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:74)

Disease	PMID	Source
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute myeloid leukemia	21251322	CNVD
lymphocytic leukemia	21291569	CNVD
Cancer	20164920	CNVD
Myelodysplastic syndrome	21251322	CNVD
Colorectal cancer	16272173	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Multiple myeloma	17550852	CNVD
Ovarian cancer	21720365	CNVD
Salivary gland tumor	18059337	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	19377443	CNVD
Prostate cancer	16461572	CNVD
Myelofibrosis	22110671	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Glaucoma	21310917	CNVD
Glioblastoma multiforme	22286061	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18194544	CNVD
Prostate cancer	22341455	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:801 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:119941800-119950200	Weak transcription	Skeletal Muscle Female	skeletal muscle
2	chr5:119942600-119952800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr5:119948200-119952000	Enhancers	Osteobl	bone
4	chr5:119948600-119950400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr5:119948600-119952000	Enhancers	HSMM	muscle
6	chr5:119949200-119950400	Enhancers	NH-A	brain
7	chr5:119949200-119953000	Enhancers	NHLF	lung
8	chr5:119949400-119950200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr5:119949400-119950600	Enhancers	Brain Cingulate Gyrus	brain
10	chr5:119949400-119951000	Enhancers	Breast Myoepithelial Primary Cells	Breast
11	chr5:119949400-119951800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
12	chr5:119949400-119952400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
13	chr5:119949400-119953000	Enhancers	HMEC	breast
14	chr5:119949400-119953000	Enhancers	NHEK	skin
15	chr5:119949600-119950400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr5:119949600-119950600	Enhancers	Fetal Lung	lung
17	chr5:119949600-119950600	Flanking Active TSS	NHDF-Ad	bronchial
18	chr5:119949600-119950800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr5:119949600-119951000	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
20	chr5:119949600-119951200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
21	chr5:119949600-119951200	Enhancers	Cortex derived primary cultured neurospheres	brain
22	chr5:119949600-119952000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
23	chr5:119949800-119950600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
24	chr5:119949800-119950600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
25	chr5:119949800-119950600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr5:119949800-119950600	Enhancers	Brain Substantia Nigra	brain
27	chr5:119949800-119950600	Enhancers	Duodenum Smooth Muscle	Duodenum
28	chr5:119949800-119950600	Enhancers	Fetal Brain Female	brain
29	chr5:119949800-119950600	Enhancers	Rectal Smooth Muscle	rectum
30	chr5:119949800-119950800	Enhancers	Fetal Brain Male	brain
31	chr5:119949800-119951600	Weak transcription	Placenta Amnion	Placenta Amnion
32	chr5:119949800-119953000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
33	chr5:119950000-119950600	Enhancers	Aorta	Aorta
34	chr5:119950000-119950600	Enhancers	Skeletal Muscle Male	skeletal muscle
35	chr5:119950000-119950600	Flanking Active TSS	HSMMtube	muscle
36	chr5:119950000-119950800	Enhancers	Brain Germinal Matrix	brain
37	chr5:119950000-119950800	Enhancers	Brain Hippocampus Middle	brain
38	chr5:119950000-119951000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
39	chr5:119950000-119951400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr5:119950200-119950600	Enhancers	Brain Inferior Temporal Lobe	brain
41	chr5:119950200-119951000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
42	chr5:119950400-119950600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
43	chr5:119950400-119950600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
44	chr5:119950400-119950600	Enhancers	Psoas Muscle	Psoas
45	chr5:119950400-119950600	Enhancers	Skeletal Muscle Female	skeletal muscle
46	chr5:119950400-119950800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr5:119950400-119950800	Enhancers	Brain Anterior Caudate	brain
48	chr5:119950400-119950800	Enhancers	Fetal Heart	heart
49	chr5:119950400-119950800	Flanking Active TSS	NH-A	brain
50	chr5:119950400-119951000	Enhancers	Primary hematopoietic stem cells	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links